Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK

• Asıl Yazarlar: Eklund O (Yazar), Afzal F (Yazar), Borgström F (Yazar), Flavin J (Yazar), Ternouth A (Yazar), Ojanguren ME (Yazar), Crespo C (Yazar), Baldwin M (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Dove Medical Press, 2016-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Oskar Eklund,1 Faraz Afzal,2 Fredrik Borgström,1 Jason Flavin,3 Andrew Ternouth,4 Maria Eugenia Ojanguren,5 Carlos Crespo,5 Mike Baldwin6 1Quantify Research AB, Stockholm, Sweden; 2Boehringer Ingelheim, Asker, Norway; 3Boehringer Ingelheim, Burlington, ON, Canada; 4Boehringer Ingelheim, Bracknell, B...